B
TMO icon

Braidwell’s Thermo Fisher Scientific TMO Stock Holding History

Braidwell’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.8M Sell
89,395
-3,520
-4% -$1.69M 1.66% 19
2026
Q1 		$45.7M Buy
92,915
+12,190
+15% +$6.62M 1.52% 23
2025
Q4 		$46.8M Sell
80,725
-33,208
-29% -$18.8M 1.5% 26
2025
Q3 		$55.3M Sell
113,933
-21,300
-16% -$9.91M 1.64% 22
2025
Q2 		$54.8M Buy
135,233
+7,500
+6% +$3.14M 1.88% 21
2025
Q1 		$63.6M Buy
127,733
+37,979
+42% +$20.6M 2.23% 15
2024
Q4 		$46.7M Buy
+89,754
New +$49.3M 1.38% 27
2024
Q3 		– Sell
-70,449
Closed -$39M – 88
2024
Q2 		$39M Buy
70,449
+23,300
+49% +$13.3M 1.22% 35
2024
Q1 		$27.4M Sell
47,149
-28,600
-38% -$16M 0.88% 42
2023
Q4 		$40.2M Hold
75,749
– – 1.48% 25
2023
Q3 		$38.3M Buy
75,749
+48,449
+177% +$25.8M 1.21% 32
2023
Q2 		$14.2M Buy
+27,300
New +$14.7M 0.47% 61

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Braidwell's TMO Position: Q2 2026 in Review

Braidwell reduced its Thermo Fisher Scientific (TMO) stake by 3.8% in Q2 2026, selling an estimated $1.69M and leaving 89,395 shares worth $44.8M. The position accounts for 1.66% of the portfolio, ranked #19.

Braidwell first reported a position in TMO in Q2 2023 and has held it in 12 quarters since. The position peaked at $63.6M in Q1 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Braidwell held 89,395 shares of Thermo Fisher Scientific worth $44.8M as of Q2 2026.
  • Braidwell sold 3,520 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.69M.
  • Thermo Fisher Scientific made up 1.66% of Braidwell's portfolio in Q2 2026, its #19 holding.
  • Braidwell first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 12 quarters since.
  • Braidwell's Thermo Fisher Scientific position peaked at $63.6M in Q1 2025.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.